tiprankstipranks
Trending News
More News >
Poolbeg Pharma Ltd. (GB:POLB)
LSE:POLB
UK Market

Poolbeg Pharma Ltd. (POLB) Financial Statements

Compare
26 Followers

Poolbeg Pharma Ltd. Financial Overview

Poolbeg Pharma Ltd.'s market cap is currently £35.21M. The company's EPS TTM is p-0.004; its P/E ratio is -4.43; Poolbeg Pharma Ltd. is scheduled to report earnings on September 29, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit£ -114.00K£ -26.00K£ -26.00K£ -18.00K
Operating Income£ -6.62M£ -5.04M£ -4.99M£ -2.38M
EBITDA£ -6.00M£ -4.66M£ -4.75M£ -2.32M
Net Income£ -5.79M£ -3.93M£ -4.69M£ -2.34M
Balance Sheet
Cash & Short-Term Investments£ 7.82M£ 12.17M£ 16.19M£ 20.95M
Total Assets£ 10.25M£ 15.43M£ 19.29M£ 23.02M
Total Debt£ 0.00£ 0.00£ 0.00£ 0.00
Net Debt£ -7.82M£ -12.17M£ -16.19M£ -20.95M
Total Liabilities£ 974.00K£ 986.00K£ 966.00K£ 438.00K
Stockholders' Equity£ 9.27M£ 14.44M£ 18.32M£ 22.58M
Cash Flow
Free Cash Flow£ -4.78M£ -4.02M£ -4.96M£ -2.23M
Operating Cash Flow£ -4.65M£ -3.85M£ -4.37M£ -2.15M
Investing Cash Flow£ 299.00K£ 359.00K£ -388.00K£ -81.00K
Financing Cash Flow£ 0.00£ 0.00£ 0.00£ 23.18M
Currency in GBP

Poolbeg Pharma Ltd. Earnings and Revenue History

Poolbeg Pharma Ltd. Debt to Assets

Poolbeg Pharma Ltd. Cash Flow

Poolbeg Pharma Ltd. Forecast EPS vs Actual EPS